![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-beclomethasone-dipropionate-3888.pdf
https://pharmafile.com/news/lupin-healthcare-launches-beclu-carbon-neutral-inhalers-for-asthma-treatment/
http://www.pharmafile.com/news/730650/nhs-scotland-recommends-chiesi-s-trimbow-asthma
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-qvar-20911-beclomethasone-dipropionate-40-mcgactuation-and-80-mcgactuation-1582965230.pdf
https://psnc.org.uk/our-news/class-3-fmd-medicines-recall-beconase-aqueous-nasal-spray-glaxo-wellcome-uk-ltd-t-a-gsk/
https://www.federalregister.gov/documents/2019/04/04/2019-06552/determination-that-qvar-40-and-qvar-80-beclomethasone-dipropionate-hfa-inhalation-aerosol-40
https://www.pharmacompass.com/pdf/news/chiesi-farmaceuticis-riarify-beclometasone-formoterol-glycopyrronium-bromide-receives-approval-in-europe-1524809608.pdf
https://www.raps.org/news-and-articles/news-articles/2018/2/ema%E2%80%99s-chmp-recommends-five-new-medicines-for-appro?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails&_zs=VHOsL1&_zl=k7BK4
http://www.pharmatimes.com/news/five_new_medicines_backed_for_eu_approval_1223972
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/02/news_detail_002907.jsp&mid=WC0b01ac058004d5c1
https://www.pharmacompass.com/pdf/news/chiesi-farmaceuticis-trimbow-beclometasone-formoterol-glycopyrronium-bromide-receives-approval-in-europe-1502451025.pdf
http://www.pharmatimes.com/news/eu_nod_for_chiesis_copd_therapy_1199305
http://www.pharma-excipients.ch/2016/03/14/dispersibility-of-lactose-fines-as-compared-to-api-in-dry-powders-for-inhalation/
http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/2015/anvisa+aprova+medicamentos+ineditos+para+asma%2C+hipertensao+pulmonar+e+tumor+cerebral
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1087-2015&w=06032015&lang=eng